The IDF Europe study on Access to Quality Medicines and Medical Devices for Diabetes Care in Europe highlights disparities in access to medicines and devices for diabetes care in the 47 countries of the IDF Europe Region.
The first of its kind in the field of diabetes, this study aims to provide evidence to policy makers and stakeholders on the current challenges faced by people living with diabetes in terms of access to the treatment they need.
Based on over 1,150 answers to a survey questionnaire, interviews and desk research, the study assesses key dimensions of access (availability, accessibility, affordability, quality and equity) for a range of treatment options used in diabetes care at national level, while offering a comparative, regional perspective that may inspire new solutions based on other countries’ experiences.
The study is structured around 5 Sub-Regional Analysis, completed by a detailed Country Profile for each of the country covered by the report.
Documents to download
To be able to use all the functionalities of the full study, download the interactive glossary and save the files in the same folders
Flipping book version
You can access the flip-page version of the study here or below.
IDF Europe would like to thank DEXCOM, Johnson & Johnson, Medtronic, Novartis, Novo Nordisk, Sanofi and particularly Lilly Diabetes for their generous support for this publication.